The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 12 results:
Author Title Type [ Year(Asc)]
Filters: Author is Ferro, Charles J  [Clear All Filters]
2020
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  Erratum.. Nephrol Dial Transplant. 35(8), 1452.
Loutradis, C., Ferro C. J., & Sarafidis P. (2020).  Hypertension Management in Patients With Autosomal Dominant Polycystic Kidney Disease: Time for a Paradigm Shift?. Am J Kidney Dis. 76(5), 743.
Ferro, C. J., Sarafidis P., & Ortiz A. (2020).  Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.. N Engl J Med. 382(21), e65.
Raptis, V., Loutradis C., Boutou A. K., Faitatzidou D., Sioulis A., Ferro C. J., et al. (2020).  Serum Copeptin, NLPR3, and suPAR Levels among Patients with Autosomal-Dominant Polycystic Kidney Disease with and without Impaired Renal Function.. Cardiorenal Med. 1-12.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 35(10), 1825.
Sarafidis, P., Loutradis C., Ferro C. J., & Ortiz A. (2020).  SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?. Am J Nephrol. 51(7), 553-555.
Loutradis, C., Sarafidis P. A., Ferro C. J., & Zoccali C. (2020).  Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management.. Nephrol Dial Transplant.
2019
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2019).  Author Correction: Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 15(2), 121.
Pappaccogli, M., Labriola L., Van der Niepen P., Pruijm M., Vogt L., Halimi J-M., et al. (2019).  Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views.. Nephrol Dial Transplant. 34(9), 1612-1615.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
2018
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2018).  Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 14(12), 727-749.
2017
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C. J., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidne. Nephrol Dial Transplant. 32(4), 620-640.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.